Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section

Grants

Current research conducted by the faculty and students of the Department of Pharmacy Systems, Outcomes and Policy is listed.

The Department of Pharmacy Systems, Outcomes and Policy is committed to conducting research that is relevant and leads to improvements in pharmacy and health care that ultimately impacts patient outcomes. Research conducted by faculty and students may be theoretical or applied and is often interdisciplinary in nature, requiring collaboration across the health sciences and other fields. This research is facilitated by strong partnerships with local, national, and international companies, with government agencies, managed care organizations, pharmaceutical manufacturers, health provider organizations, professional associations, and with other national and international university-based researchers.

The research of the Department is nationally and internationally renowned and is funded by top governmental agencies, foundations, and pharmaceutical companies. Particular research strengths of the Department include 1) pharmacoeconomics and outcomes research (including health-related quality of life, and medication adherence), 2) pharmacoepidemiology and drug safety, 3) pharmacy systems and policy (including medication and health disparities, and pharmacy services research).

Listed below are selected current or recently funded research projects being conducted by the faculty and students of the Department.

Awarded before 2017

2015 Center of Excellence for Comparative Effectiveness Research (CER) Education. Funding Source: PhRMA Foundation. PSOP Investigators: Pickard AS (PI), Schumock GT (PI). Period: January 2015 – December 2017. Award: $250,000.

Action Intervention: Physical Activity in Minority Women with Asthma. Funding Source: National Heart, Lung, and Blood Institute. PSOP Investigator: Sharp LK (Primary Mentor). Period: 2016 – 2020. Award: $721,455.

Asthma Action and Erie Trial. Funding Source: National Institute of Health. PSOP Investigator: Walton SM (Co-I). Period: April 2015 – March 2020. Award: $3,454,446 ($717,392).

Beliefs and Attitudes Towards Antipsychotic Use in Patients with Schizophrenia and Bipolar Disorder. Funding Source: Sunovion Pharmaceuticals. PSOP Investigator: Touchette DR (PI). Period: September 2013 – December 2017. Award: $354,304.

Commonly Used Medications and Multiple Myeloma Risk. Funding Source: Vahlteich Research Scholar Award, UIC College of Pharmacy. PSOP Investigator: Calip GS (PI). Period: February 2015 – February 2017.

Control Systems for Artificial Pancreas Use during and After Exercise. Funding Source: National Institute of Diabetes, Digestive & Kidney Diseases. PSOP Investigator: Sharp LK (Co-I). Period: 2013 – 2018. Award: $2,478,076.

Economic and Major Clinical Outcomes of an Innovative Integrated Pediatric Care Program. Funding Source: Department of Health and Human Services. PSOP Investigator: Touchette DR (PI). Period: September 2015 – September 2017. Award: $85,741.

EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use. Funding Source: Agency for Healthcare Research and Quality. PSOP Investigator: Walton SM (Subcontract PI). Period: September 2014 – August 2017. Award: $89,559.

Evaluation of a Novel Medication Use Health and Wellness Solution in Patients with Diabetes. Funding Source: Cardinal Health. PSOP Investigator: Touchette DR (PI). Period: January 2016 – December 2017. Award: $174,636.

Evaluation Plan for Prescription Drug Overdose Prevention for States: Illinois. Funding Source: Center for Disease Center/Dept Public Health (Illinois). PSOP Investigator: Lee TA (PI), Pickard AS. Period: September 2015 – September 2019. Award: $420,000.

Fault-Tolerant Control Systems for Artificial Pancreas. Funding Source: National Institute of Diabetes, Digestive & Kidney Diseases. PSOP Investigator: Sharp LK (Co-I). Period: 2013 – 2018. Award: $1,953,640.

Health Economics and Outcomes Research Fellowship. Funding Source: AbbVie. PSOP Investigator: Nutescu EA (PI). Period: October 2016 – October 2018. Award: $172,451.

Measuring Disparities in the Chain of Survival Among Hispanic Communities. Funding Source: American Heart Association. PSOP Investigator: Sharp LK (Mentor). Period: 2016 – 2018. Award: $153,877.

mHealth Diabetes Adherence Support. Funding Source: National Institute of Diabetes, Digestive & Kidney Diseases. PSOP Investigator: Sharp LK (Co-I). Period: 2016 – 2021. Award: $3,353,796.

Mobilizing for Patient Adherence to Cancer Therapies (mPACT). Funding Source: McKesson Foundation, Mobilizing for Health® Program. PSOP Investigator: Crawford SY (PI). Period: April 2014 – September 2017. Period: $250,000.

Multiple Sclerosis (MS) Outcomes Research. Funding Source: OSF Foundation / Central Illinois MS Clinic Fund / Caterpillar Foundation Matching Grant. PSOP Investigator: Asche CV (PI). Period: July 2015 – August 2018. Award: $500,000.

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients. Funding Source: Funded by National Institutes of Health. PSOP Investigators: Nutescu EA (PI), Schumock GT (Co-Mentor). Period: Feburary 2013 – January 2017. Award: $526,567.

Pharmacist Led Personalized Medicine Program to Improve Medication Use Safety. Funding Source: American Society of Health System Pharmacists Research and Education Foundation. PSOP Investigator: Nutescu EA (PI). Period December 2015 – December 2018. Award: $50,000.

Pharmacogenetics Implementation and Optimization at UI-Health. Funding Source: University of Illinois Office of the Vice President for Health Affairs. PSOP Investigator: Nutescu EA (PI). Period: August 2012 – December 2017. Amount: $390,000.

Pharmacomechanical Catheter Directed Thrombolysis for Acute Deep Vein Thrombosis. Funding Source: National Institute for Health /National Heart, Lung, and Blood Insitute. PSOP Investigator: Nutescu EA (Co-I). Period: May 2012 – December 2017. Award: $7,194,970.

Pharmacy Accessibility and Place-Based Disparities in the Use of Cardiovascular Medications in Older Adults. Funding Source: National Institute on Aging. PSOP Investigator: Qato DM (PI). Period: January 2015 – December 2017. Amount: $442,000.

Precision Medicine-African American Cardiovascular Pharmacogenetics CONsorTium (ACCOuNT): Discovery and Translation. Funding Source: National Institute of Health/National Institute of Minority Health and Health Disparities. PSOP Investigator: Nutescu EA (Site PI). Period: August 2016 – May 2021. Award: $9,534,933.

Promoting Healthy Seafood Choices in Asian Communities. Funding Source: National Institute of Health. PSOP Investigator: Sharp LK (Co-I). Period: 2015 – 2021. Award: $2,720,184.

Promoting Senior’s Health with Home Care Aides: A Randomized Controlled Trial. Funding Source: National Institute on Aging. PSOP Investigator: Walton SM (Co-I). Period: September 2016 – April 2021. Award: $3,951,711 ($636,316).

Randomized Controlled Trial of Patient-Centered Self-Monitoring in Minority Patients. Funding Source: Roche Diagnostics Corporation. PSOP Investigator: Nutescu EA (PI). Period: June 2015 – December 2017. Award: $228,060.

Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study). Funding Source: Agency for Healthcare Research and Quality. PSOP Investigator: Sharp LK (Co-I), Lee TA (Co-I). Period: 2016 – 2020. Award: $1,500,000.

Segregation, Pharmacy Characteristics, and Disparities in Statin Adherence. Funding Source: National Institute for Aging. PSOP Investigators: Qato DM (PI), Touchette DR (Co-I). Period: July 2015 – June 2017. Award: $248,719.

Sentinel Initiative. Funding Source: Food and Drug Administration. PSOP Investigators: Schumock GT (Site PI), Lee TA and Pickard AS (site Co-I). Period: January 2015 – December 2020. Award: Task-order based funding.

Takeda Pharmaceuticals International and UIC 2-Year Fellowship in Medication Adherence. Funding Source: Takeda Pharmaceuticals. PSOP Investigator: Touchette DR (PI). Period: July 2015 – June 2017. Award: $164,834.

Takeda Pharmaceuticals International and UIC 2-Year Fellowship in Medication Adherence. Funding Source: Takeda Pharmaceuticals. PSOP Investigator: Touchette DR (PI). Period: July 2016 – June 2018. Award: $172,532.

Takeda-UIC 2-Year Fellowship in Health Economics and Outcomes Research. Funding Source: Takeda. PSOP Investigator: Pickard AS (PI). Period: July 2016 – June 2018. Award: $161,000.

Takeda-UIC 2-Year Fellowship in Health Economics and Outcomes Research. Funding Source: Takeda. PSOP Investigator: Pickard AS (PI). Period: July 2015 – June 2017. Award: $161,000.  

Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial. Funding Source: National Institute of Diabetes and Digestive and Kidney Diseases. PSOP Investigator: Walton SM (Subcontract PI). Period: August 2015 – May 2019. Award: $66,771 ($15,910).

The Impact of a Gene Expression Profile on Treatment Choice and Outcome among Minority Men Newly Diagnosed with Prostate Cancer: A Randomized Trial. Funding Source: Department of Defense. PSOP Investigator: Sharp LK (Co-I). Period: 2015 – 2018. Award: $2,836,177.

The Virtual Assistant Health Coach:  Learning to Autonomously Improve Health Behaviors. Funding Source: National Science Foundation. PSOP Investigator: Sharp LK (Co-I). Period: 2016 – 2017. Award: $203,782.

Training in CVD Epidemiology and Related Chronic Diseases in Minority Populations. Funding Source: National Heart, Lung, and Blood Institute. PSOP Investigator: Lee TA (Mentor). Period: April 2015 – March 2020.

A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens. Funding Source: National Institute on Aging. PSOP Investigator: Walton SM (Subcontract PI). Period: September 2015 – May 2020. Award: $98,229 ($30,835).

Awarded in 2017

Additional Signals for Detection of Exercise, Stress and Sleep Effects and Effects and Predication of Glucose Levels for Next Generation AP Systems. Funding Source: Juvenile Diabetes Research Foundation. PSOP Investigator: Sharp LK (Co-I). Period: 2017 – 2018. Award: $250,000.

An Etiology for Medication Ordering Errors in CPOE Systems. Funding Source: Agency for Healthcare Research and Quality. PSOP Investigator: Touchette DR (Co-I). Period: August 2017 – July 2019. Award: $299,999.

An Evaluation of Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological Adverse Events and Improve Quality of Life. Funding Source: Veloxis Pharmaceuticals. PSOP Investigator: Walton SM (Co-I). Period: June 2017 – May 2018. Award: $87,600.

Bringing Together Experts and Stakeholders to Explore How to Reduce Transitions from

Assisted Living to Residential Care by Leveraging Available Technologies. Funding Source: Convening and Collaborating (C2) Award, Michael Smith Foundation for Health Research 2017. PSOP Investigator: Asche CV. Period: February 2017 – February 2018. Award: $15,000.

Community-Partnership to Address the Problem of Pharmacy Peserts on Chicago’s South Side. Funding Source: Institute for Research on Race and Public Policy, University of Illinois at Chicago. PSOP Investigator: Qato DM (PI). Period: July 2017 – July 2018. Amount: $5,000.

Dental Prescribing of Antibiotics and Opioids: High Use in the Absence of Evidence. Funding Source: Agency for Healthcare Research and Quality: R01. PSOP Investigator: Suda KJ (PI), Calip GS (Co-I). Period: August 2017-July 2021.

Developing a Patient-Led Multiple Sclerosis (MS) Research Community. Funding Source: Patient Centered Outcomes Research Institute Pipeline to Proposal Tier 3 Award. PSOP Investigator: Asche CV (Project Leader). Period: August 2017 – July 2018. Award: $50,000.

Economic Evaluation of Erenumab in the Prophylactic Treatment of MigraineI. Funding Source: Institute for Clinical and Economic Review. PSOP Investigators: Touchette DR (PI), Lee TA (Co-I), Walton SM (Co-I). Period: November 2017 – June 2018. Award: $125,000.

Expanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist-Driven Model. Funding Source: Gilead Sciences. PSOP Investigator: Lee TA (Co-I). Period: December 2017 – November 2018. Award: $168,327.

Impact of the VA Copay Change on Perception and Utilization of Pharmacy Benefits by Veterans. Funding Source: Department of Veterans Affairs: HSR&D IIR Merit Award. PSOP Investigator: Suda KJ (Co-I). Period: October 2017-September 2021.

Inflammatory Cytokines in Multiple Sclerosis Patients with Obstructive Sleep Apnea. Funding Source: Illinois Neurological Institute Council. PSOP Investigator: Asche CV (Co-I). Period: Spring 2017. Award: $4,770.

Institute for Clinical and Economic Review Modeling Studies. Funding Source: Institute for Clinical and Economic Review. PSOP Investigators: Touchette DT (PI), Walton MS, Schumock GT, Lee TA, Pickard AS. Period: March 2017 – March 2018. Award: $125,000/year.

Institute for Clinical and Economic Review Consulting Contract. Funding Source: Institute for Clinical and Economic Review. PSOP Investigators: Touchette DR (PI), Lee TA (Co-I), Pickard AS (Co-I), Schumock GT (Co-I), Walton SM (Co-I). Period: March 2017 – March 2018. Award: $125,000

Medication Safety Systems in the Community: The Role of Pharmacists. Funding Source: Gordon E. and Betty I Moore Foundation. PSOP Investigators: Schumock GT (PI), Crawford SY (PI), Bauman JL, Manasse HR, Jr., Durley SF. Period: June 2017 – December 2017. Award: $77,130.

mHealth Diabetes Adherence Support. Funding Source: National Institute of Diabetes, Digestive & Kidney Diseases. PSOP Investigator: Sharp LK (Co-PI). Period: 2017 – 2019. Award: $223,860.

Multilevel HIV Prevention for South African Adolescent Girls and Young Women. Funding Source: National Institutes of Health. PSOP Investigator: Walton SM (Co-I). Period: June 2017 – May 2022. Award: $2,474,588 ($487,995).

Pharmacy Deserts, Access to Medicines and Community Health. Funding Source: Blue Cross Blue Shield Association. PSOP Investigator: Qato DM (PI). Period: January 2017 – January 2018. Amount: $70,000.

Second Generation Antipsychotics on Diabetes Outcomes in Major Depression. Funding Source: National Institutes of Mental Health. PSOP Investigators: Xing S (PI), Lee TA, Calip GS, Schumock GT. Period: August 2017 – August 2018. Award: $28, 044.

The Cost Effectiveness of School-Based Supervised Asthma Therapy. Funding Source: National Heart, Lung, and Blood Institute. PSOP Investigator: Lee TA (Co-I). Period: August 2013 – April 2017. Award: $3,155,975

The Problem of Pharmacy Closures on Chicago’s South and West Sides: A Community-Led Response. Funding Source: Robert Wood Johnson Foundation Clinical Scholars Program. PSOP Investigator: Qato DM (PI). Period: September 2017 – August 2020. Amount: $210,000.

Transplant Regimen Adherence in Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial. Funding Source: National Institute of Diabetes and Digestive and Kidney Diseases. PSOP Investigator: Walton SM (Subcontract PI). Period: April 2017 – March 2021. Award: $89,017.

UIC/AbbVie Fellowship in Pharmacovigilance and Patient Safety. Funding Source: AbbVie Inc. PSOP Investigator: Calip GS (PI). Period: October 2017 – September 2018.

Voices in Motion: An Intergenerational Community Choir to Support Social Inclusion and Quality of Life for Persons with Alzheimer’s Disease (AD) and Their Caregivers. Funding Source: Alzheimer’s Research Foundation. PSOP Investigator: Asche CV (Co-I). Period: September 2017 – August 2019. Award: $238,260 (Canadian).

Top